|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
RuiYi Inc., a San Diego-Shanghai biotech, signed an exclusive license with Genor BioPharma of Shanghai to develop RuiYi’s lead molecule in China; RuiYi also enlisted CMC Biologics to develop a cell... Read More
from ChinaBio® Today
|